Lagging Behind Regional Peers

The Croatian market is small and behind many of its regional neighbours, including Hungary, despite its relatively advanced status. At more than 70% by value, generics - comprising mostly relatively expensive branded generics - meet the bulk of demand for pharmaceuticals, with the segment continuing to be boosted by healthcare debts, cost-containment initiatives and the support for the strong domestic generics industry in the face of distinct intellectual property (IP) deficiencies.

To read the full article, please sign in or take a free trial.